Vimarsana
Biggest News Aggregation in the World

Page 17 - Special Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Special Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Special Access Program Today - Breaking & Trending Today

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More - Vimarsana News

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More

Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and effica...

Canadian Veteran Receives Approval for APEX's Psilocybin Therapy Through Health Canada's Special Access Program - Vimarsana News

Canadian Veteran Receives Approval for APEX's Psilocybin Therapy Through Health Canada's Special Access Program

/PRNewswire/ - Apex Labs Ltd. (APEX or the Company), a pharmaceutical company transforming the standard of mental health care with psilocybin treatments is...

EXCLUSIVE - Canada Approves First Legal Medical Psilocybin Access: Veteran To Undergo Apex's Macrodose Therapy - Vimarsana News

EXCLUSIVE - Canada Approves First Legal Medical Psilocybin Access: Veteran To Undergo Apex's Macrodose Therapy

Editor's note: This story has been updated to clarify that Kelsi Sheren's treatment does not represent the first legal access to medical psilocybin in Canada. 

EXCLUSIVE - Vimarsana News

EXCLUSIVE

Health Canada’s Special Access Program (SAP) has authorized a physician to provide Apex Labs’ psilocybin macrodose drug protocol to patient Kelsi Sheren, a…

Source: biztoc.com
Canada Approves Legal Medical Psilocybin Access For Veteran, To Undergo Apex's Macrodose Therapy (CORRECTED) - Vimarsana News

Canada Approves Legal Medical Psilocybin Access For Veteran, To Undergo Apex's Macrodose Therapy (CORRECTED)

Editor's note: This story has been updated to clarify that Kelsi Sheren's treatment does not represent the first legal access to medical psilocybin in Canada.